Summary of the technology
Derivatives of cannabinoids have an antimicrobial and anti biofilm effect on pseudomonas and candida which are major ethological pathogenic factors in CF
Project ID : 6-2019-6720
Description of the technology
Cystic Fibrosis (CF) is an inherited disorder that causes severe damage to the lungs, digestive system and other organs in the body. There is no known cure for cystic fibrosis and the average life expectancy is between 42 and 50 years in the developed world. Lung problems are responsible for death in 80% of people with CF.
Our Invention suggests a novel regime of treatment using naturally occurring compounds with little side effects, to fight pathogenic factors common to CF, affecting the microbial biofilm in the lungs and reducing the need of antibiotics/antifungal drugs.
Specifically, the anti-bacterial, anti-fungal anti-biofilm effects on Candida albicans and Pseudomonas aeruginosa, both common to CF patients, is demonstrated.